Search research articles
Contact Us
Filters
Showing results (11-20 of 63) with videos related to
Page
of 7
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 29, 2022
Rapid and highly sensitive approach for multiplexed somatic fusion detection
Samuel Abbou, Sarah Finstuen-Magro, Brigit McDannell, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 22, 2026
Spatially resolved T cell receptor tracking reveals γδT cell localization to tumor-rich regions in high-risk neuroblastoma: A Report from the Children's Oncology Group
Yiyue Jiang, Wenbao Yu, Yanan Wang, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
April 15, 2026
Liquid Biopsy for Cancer Screening in Li-Fraumeni Syndrome: Interest in Clinical Trial and Reported Barriers to Standard of Care Screening
Suzanne P MacFarland, Victoria E Goodman, Sara King-Dowling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2023
Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA
Peter Anderson, Maurizio Ghisoli, Brian D Crompton, et al.
Cancer Research
|
March 29, 2013
High-throughput tyrosine kinase activity profiling identifies FAK as a candidate therapeutic target in Ewing sarcoma
Brian D Crompton, Anne L Carlton, Aaron R Thorner, et al.
JCO Precision Oncology
|
February 23, 2019
Detection of Circulating Tumor DNA in Patients With Leiomyosarcoma With Progressive Disease
Matthew L Hemming, Kelly S Klega, Justin Rhoades, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma
Laura M Madanat-Harjuoja, Kelly Klega, Yao Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 17, 2022
Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533
Laura M Madanat-Harjuoja, Lindsay A Renfro, Kelly Klega, et al.
British Journal of Cancer
|
October 11, 2022
Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children's Oncology Group
David S Shulman, Sonja Chen, David Hall, et al.
JCO Precision Oncology
|
July 21, 2018
Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors
Kelly Klega, Alma Imamovic-Tuco, Gavin Ha, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 63) with videos related to
Sort By:
Page
of 7
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 29, 2022
Rapid and highly sensitive approach for multiplexed somatic fusion detection
Samuel Abbou, Sarah Finstuen-Magro, Brigit McDannell, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 22, 2026
Spatially resolved T cell receptor tracking reveals γδT cell localization to tumor-rich regions in high-risk neuroblastoma: A Report from the Children's Oncology Group
Yiyue Jiang, Wenbao Yu, Yanan Wang, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
April 15, 2026
Liquid Biopsy for Cancer Screening in Li-Fraumeni Syndrome: Interest in Clinical Trial and Reported Barriers to Standard of Care Screening
Suzanne P MacFarland, Victoria E Goodman, Sara King-Dowling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2023
Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA
Peter Anderson, Maurizio Ghisoli, Brian D Crompton, et al.
Cancer Research
|
March 29, 2013
High-throughput tyrosine kinase activity profiling identifies FAK as a candidate therapeutic target in Ewing sarcoma
Brian D Crompton, Anne L Carlton, Aaron R Thorner, et al.
JCO Precision Oncology
|
February 23, 2019
Detection of Circulating Tumor DNA in Patients With Leiomyosarcoma With Progressive Disease
Matthew L Hemming, Kelly S Klega, Justin Rhoades, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma
Laura M Madanat-Harjuoja, Kelly Klega, Yao Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 17, 2022
Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533
Laura M Madanat-Harjuoja, Lindsay A Renfro, Kelly Klega, et al.
British Journal of Cancer
|
October 11, 2022
Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children's Oncology Group
David S Shulman, Sonja Chen, David Hall, et al.
JCO Precision Oncology
|
July 21, 2018
Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors
Kelly Klega, Alma Imamovic-Tuco, Gavin Ha, et al.
Page
of 7